Showing results (311-320 of 319) with videos related to
Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
German Medical Science : GMS E-Journal|July 14, 2025
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinomaAndreas Dietz, Kathy Taylor, Oliver Bayer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.ALTEX|May 16, 2016
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingUwe Marx, Tommy B Andersson, Anthony Bahinski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-IIA Dietz, G Wichmann, T Kuhnt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III TrialUlrich Dührsen, Stefan Müller, Bernd Hertenstein, et al.Nature Biotechnology|August 3, 2023
Systematic benchmarking of single-cell ATAC-sequencing protocolsFlorian V De Rop, Gert Hulselmans, Chris Flerin, et al.Annals of Hematology|January 6, 2019
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trialAndreas Hüttmann, Jan Rekowski, Stefan P Müller, et al.Annals of Hematology|January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group studyDietger Niederwieser, Thomas Lang, Rainer Krahl, et al.The Lancet. Infectious Diseases|November 9, 2019
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research ConsortiumOliver A Cornely, Ana Alastruey-Izquierdo, Dorothee Arenz, et al.Pageof 32